1. |
|
2. |
Perez MC,Hunt SP,Coffin RS,et al.Comparative analysis of genomic HSV vectors for gene delivery to motor neurons followingperipheral inoculation in vivo[J].Gene Ther,2004,11(13):1023-1032..
|
3. |
Scarpini CG,May J,Lachmann RH,et al.Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors[J].Gene Ther,2001,8(14):1057-1071..
|
4. |
Puskovic V,Wolfe D,Goss J,et al.Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo[J].Mol Ther,2004,10(1):67-75..
|
5. |
Saydam O,Glauser DL,Heid I,et al.Herpes simplex virus1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo[J].Mol Ther,2005,12(5):803-812..
|
6. |
Kalwy SA,Akbar MT,Coffin RS,et al.Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainic-acid-induced cell loss[J].Brain Res Mol Brain Res,2003,111(1-2):91-103..
|
7. |
Wu S,Zhou L,Rose M,et al.c-FLIP-L recombinant adeno-associated virus vector infection prevents Fas-mediated but not nerve growth factor withdrawal-mediated cell death in PC12 cells[J].Brain Research.Molecular Brain Res,2004,122(1):79-87..
|
8. |
McCown TJ.Adeno-associated virus(AAV)vectors in the CNS[J].Curr Gene Ther,2005,5(3):333-338.
|
9. |
Richichi C,Lin EJ,Stefanin D,et al.Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vectorneuropeptide Y expression in the rat hippocampus[J].JNeurosci,2004,24(12):3051-3059..
|
10. |
Danthinne X,Imperiale MJ.Production of first generation adenovirus vectors:a review[J].Gene Ther,2000,7(20):1707-1714..
|
11. |
Glover CP,Bienemann AS,Hopton M,et al.Long-term transgene expression can be mediated in the brain by adenoviral vectors when powerful neuron-specific promoters are used[J].J Gene Med,2003,5(7):554-559..
|
12. |
Ruitenberg MJ,Levison DB,Lee SV,et al.NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration[J].Brain,2005,128(Pt 4):839-853..
|
13. |
齐建国,刘柏林.中枢神经系统疾病的基因治疗[M].北京:科学出版社,2005:71..
|
14. |
Mukhtar M,Duke H,BouHamdan M,et al.Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells:an initial approach against a potential viral reservoir[J].Hum Gene Ther,2000,11(2):347-359..
|
15. |
Déglon N,Aebischer P.Lentiviruses as vectors for CNS diseases[J].Curr Top Microbiol Immunol,2002,261:191-209..
|
16. |
Fink DJ,DeLuca NA,Yamada M,et al.Design and application of HSV vectors for neuroprotection[J].Gene Ther,2000,7(2):115-119..
|
17. |
Sun Y,Jin K,Peel A,et al.Neuroglobin protects the brain from experimental stroke in vivo[J].Proc Natl Acad Sci U S A,2003,100(6):3497-3500..
|
18. |
Marples B,Scott SD,Hendry JH,et al.Development of synthetic promoters for radiation-mediated gene therapy[J].Gene Ther,2000,7(6):511-517.Comment in:Gene Ther,2000,7(19):1706.[18]Rapoport SI.Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy[J].Expert Opin Investig Drugs,2001,10(10):1809-1818..
|
19. |
Ramirez JJ,Caldwell JL,Majure M,et al.Adeno-associated virus vector expressing nerve growth factor enhances cholinergic axonal sprouting after cortical injury in rats[J].J Neurosci,2003,23(7):2797-2803..
|
20. |
Mah C,Byrne BJ,Flotte TR.Virus-based gene delivery systems[J].Clin Pharmacokinet,2002,41(12):901-911.
|